Cargando…

Identification of Cell Type-Specific Effects of DNMT3A Mutations on Relapse in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease caused by distinctive mutations in individual patients; therefore, each patient may display different cell-type compositions. Although most patients with AML achieve complete remission (CR) through intensive chemotherapy, the likelihood of rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Seo-Gyeong, Kim, Hyeoung-Joon, Kim, Mi Yeon, Kim, Dennis Dong Hwan, Shin, So-I, Ahn, Jae-Sook, Park, Jihwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590706/ https://www.ncbi.nlm.nih.gov/pubmed/37853686 http://dx.doi.org/10.14348/molcells.2023.0093

Ejemplares similares

FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
por: Ahn, Jae-Sook, et al.
Publicado: (2022)

Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia
por: Ahn, Jae‐Sook, et al.
Publicado: (2022)

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine
por: Kim, Mihee, et al.
Publicado: (2023)

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia
por: Ahn, Seo-Yeon, et al.
Publicado: (2023)

The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
por: Lee, Se Ryeon, et al.
Publicado: (2009)

Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
por: Ahn, Jae-Sook, et al.
Publicado: (2014)

Multiple Intracranial Tuberculomas Mimicking Granulocytic Sarcomas in Acute Myeloid Leukemia
por: Ahn, Jae-Sook, et al.
Publicado: (2007)

Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2010)

Characteristics of DNMT3A mutations in acute myeloid leukemia
por: Park, Dong Jin, et al.
Publicado: (2020)

OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2014)

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
por: Ahn, Jae-Sook, et al.
Publicado: (2016)

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype
por: Ahn, Jae-Sook, et al.
Publicado: (2017)

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
por: Kim, TaeHyung, et al.
Publicado: (2020)

Incidence and Prognostic Impact of DNMT3A Mutations in Korean Normal Karyotype Acute Myeloid Leukemia Patients
por: Park, Sang Hyuk, et al.
Publicado: (2015)

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients
por: Lee, Seung-Shin, et al.
Publicado: (2016)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors
por: Jang, Hyeok-Jae, et al.
Publicado: (2021)

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia
por: Zheng, Qiaoli, et al.
Publicado: (2016)

Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse
por: Park, Sang Hyuk, et al.
Publicado: (2011)

IDH1/2 mutations in acute myeloid leukemia
por: Byun, Ja Min, et al.
Publicado: (2022)

Low Frequency and Variability of FLT3 Mutations in Korean Patients with Acute Myeloid Leukemia
por: Bang, Soo-Mee, et al.
Publicado: (2008)

Sonographic Features of a Myeloid Sarcoma of the Breast as a Relapse of Acute Myeloid Leukemia After Stem-Cell Transplantation: A Case Report
por: Kim, Suk Jung, et al.
Publicado: (2019)

DNMT3A mutations in Chinese childhood acute myeloid leukemia
por: Li, Weijing, et al.
Publicado: (2017)

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation
por: Bhogal, Balpreet, et al.
Publicado: (2022)

Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data
por: Song, Ik-Chan, et al.
Publicado: (2021)

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
por: Park, Jong-Ho, et al.
Publicado: (2018)

Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia
por: Jost, E, et al.
Publicado: (2014)

DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
por: Pezzi, Annelise, et al.
Publicado: (2012)

Case report: biallelic DNMT3A mutations in acute myeloid leukemia
por: Cumbo, Cosimo, et al.
Publicado: (2023)

High Transcript Level of FLT3 Associated with High Risk of Relapse in Pediatric Acute Myeloid Leukemia
por: Kang, Hyoung Jin, et al.
Publicado: (2010)

Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients
por: Hong, Seung-Dok, et al.
Publicado: (2011)

Expression and prognosis analysis of DNMT family in acute myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2020)

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment
por: Jung, Sung-Hoon, et al.
Publicado: (2015)

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2019)

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
por: Lu, Quanyi, et al.
Publicado: (2013)

Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
por: Pezzi, Annelise, et al.
Publicado: (2014)

Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation
por: Que, Yimei, et al.
Publicado: (2021)

Central Diabetes Insipidus Induced by Acute Myeloid Leukemia with DNMT3A Mutation
por: Lakshmanan, Priyanka, et al.
Publicado: (2022)

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
por: Oñate, Guadalupe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv9ed32pqgpho2o8jdaj14rpvu